Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers

Estrogen receptor-α positive (ERα+) breast cancer accounts for approximately 70–80% of the nearly 25,0000 new cases of breast cancer diagnosed in the US each year. Endocrine-targeted therapies (those that block ERα activity) serve as the first line of treatment in most cases. Despite the proven bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Michelle M., Lee, Linus, Werfel, Thomas, Joly, Meghan M. Morrison, Hicks, Donna J., Rahman, Bushra, Elion, David, McKernan, Courtney, Sanchez, Violeta, Estrada, Monica V., Massarweh, Suleiman, Elledge, Richard, Duvall, Craig, Cook, Rebecca S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833697/
https://www.ncbi.nlm.nih.gov/pubmed/29343814
http://dx.doi.org/10.1038/s41419-017-0072-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833697/
https://www.ncbi.nlm.nih.gov/pubmed/29343814
http://dx.doi.org/10.1038/s41419-017-0072-x

Ejemplares similares